Net Cash Provided by (Used in) Operating Activities |
-2.04M |
USD |
+37.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-19K |
USD |
-135% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-70K |
USD |
+52.1% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
6.88M |
shares |
+0.9% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.13M |
USD |
+36.6% |
Q1 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
6K |
USD |
0% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
3.65M |
USD |
+23.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
4.08M |
USD |
+34.4% |
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
70K |
USD |
-52.1% |
Q1 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
22.7M |
USD |
+0.66% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
849K |
USD |
+76.1% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
432K |
USD |
+454% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
1.06M |
USD |
+37.5% |
Q3 2024 |
Q3 2024 |
Interest Expense |
23K |
USD |
+360% |
Q1 2024 |
Q1 2024 |